研究进展

慢性脱髓鞘造出一种溶酶体失灵的小胶质细胞状态

来源:Nat Neurosci · PMID 42934349 · DOI 10.1038/s41593-026-02489-5** · 来源:IMA 知识库《文献层·文献监控卡片》2026-10-29 期 · 全文级(file_id dGBunAeRiRlm,下载实测 692,872 B) · 全文已获取并通过归属校验

数据日期 2026-10-29 · 生成时间 2026-10-29 06:03

研究问题

Dysfunctional immune responses impair remyelination and contribute to neurodegeneration.

方法

Mice AllexperimentswereperformedinaccordancewiththeGermananimal welfare law and local regulations for animal experiments of Bavaria andLowerSaxony.Animalsweregrouphoused(threetofivemice)ina controlledenvironment(temperatureof22 °C,30–70%humidity,12-h dark/12-hlightcycle)andhadaccesstofoodandwateradlibitumunder specificpathogenfreeconditions.MiceinthisstudyincludeC57BL/6J, Plp1Tg25 , BALB/cNctr-Npc1m1N/J (NPC1 KO)70,71 , C57BL/6-Npc1tm1.2Apl (NPC1fl/fl )72 , Soat1tm1.1Itl (SOAT1fl/fl )73 , Apoetm1Unc (APOEKO)74 , B6.Cx3cr1tm1.1(cre)Jung/Orl (Cx3cr1-Cre)75 and B6.129P2(C)-Cx3cr1tm2.1(cre/ ERT2)Jung/J (Cx3cr1-CreERT2)75 .;C57BL/6J, Cx3cr1-CreERT2, APOEKO and SOAT1fl/fl mice were purchased from Charles River Laboratories.;NPC- 1cKOandNPC1KOmicewerekindlyprovidedbySabinaTahirovic.Plp1Tg mice were kindly provided by Klaus-Armin Nave.;Plp1Tg × APOEKO were generated by cross-breeding Plp1Tg animals with APOEKO mice.

核心结论

InPlp1Tgmice,theDAM1subpopulation,markedbypro-inflammatory cytokines and chemokines including Ccl4/Mip1b, was significantly expanded, comprising approximately 23% of all microglia (Fig. ‖ 结论:These findings suggest that free cholesterol accumulation in microglial lysosomes might drive a pro-inflammatory, myelin-toxic state that contributes to progressive pathology.

局限

全文未设独立 limitations 节;结构上为非 RCT 设计,因果推断强度受限。

对本项目的价值

★★★★★ 方法学进展决定我们能否在有限样本下检出真实效应,属基础设施级收益。顶刊证据;命中核心 蛋白稳态/自噬;最大样本量约 5;设计 单细胞、多组学。

全文来源

Nature OA PDF(正文 152,005 字符,已过标题/DOI 逐字归属校验)

原文题录

  • 英文标题:Chronic progressive demyelination induces a microglial state with lysosomal dysfunction.
  • 期刊与标识:Nat Neurosci · PMID 42934349 · DOI 10.1038/s41593-026-02489-5**

A 级证据分级:A 级(同行评议人体研究)

本文属人体研究证据,但需注意:观察性或小样本干预的结论不等于已证实临床获益;效应量与长期安全性仍需更大规模、更长随访的试验验证。

关于本文的文献来源:本站依据 IMA 知识库「五刊监控·深度文献卡片」撰写,依据已获取的期刊全文(方法、样本量与结论已回到原文核对);未能获取全文的同批条目另行标注「摘要级」,全程未做任何数值推算补全。